Metastatic osimertinib mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

K562 Cells Philadelphia Chromosome Cell Line, Tumor Chromosomes, Human, Pair 9 Neoplastic Stem Cells Cells, Cultured Myeloid Progenitor Cells Orbit Bone Marrow HL-60 Cells Fibroblasts Skin Stromal Cells Hematopoietic Stem Cells Tumor Cells, Cultured Cell Line Bone Marrow Cells Dendritic Cells

Organisms6

Mice, SCID Mice, Nude Mice, Inbred BALB C Rats, Sprague-Dawley Mice, Inbred NOD Dogs

Diseases48

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Mastocytosis, Systemic Dermatofibrosarcoma Fibromatosis, Aggressive Lichenoid Eruptions Nausea Leukemia, Myeloid, Accelerated Phase Primary Myelofibrosis Neoplasm, Residual Vomiting Recurrence Neutropenia Histiocytoma, Malignant Fibrous Scleroderma, Systemic Thrombocytopenia Disease Progression Graves Ophthalmopathy Fibrosis Anorexia Spinal Cord Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasms Leukemia Pulmonary Fibrosis Neoplasm Metastasis Nerve Sheath Neoplasms Myeloproliferative Disorders Bone Neoplasms Chromosome Aberrations Peritoneal Neoplasms Peripheral Nervous System Diseases Skin Neoplasms Carcinoma, Small Cell Brain Neoplasms Neoplasm Recurrence, Local Disease Models, Animal Osteosarcoma Necrosis Liver Neoplasms Melanoma

Chemicals and Drugs104

Benzamides Piperazines Pyrimidines Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor beta Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Mesylates Pergolide Fenoldopam Enzyme Inhibitors Pefloxacin Benzoxazines Delavirdine Receptors, Platelet-Derived Growth Factor Tubulin Modulators Pralidoxime Compounds Quinolizines Nelfinavir Naphthalenes Gabexate Proto-Oncogene Proteins c-sis Antimitotic Agents Morpholines Pyrroles Cannabinoid Receptor Agonists Ergolines Dihydroergotoxine Cannabinoids Bromocriptine Harringtonines mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Doxazosin Rifabutin Indoles Interferon-alpha Receptors, Glucocorticoid Dexamethasone STAT5 Transcription Factor Receptors, Cannabinoid Phentolamine Hydroxyurea Platelet-Derived Growth Factor Lipid Peroxides RNA, Messenger Thiazoles Piperidines Stem Cell Factor Receptor, Cannabinoid, CB1 Adrenergic alpha-Antagonists Free Radical Scavengers Cannabinoid Receptor Antagonists Antiemetics Oncogene Proteins, Fusion Pyrazoles Milk Proteins Camptothecin Topotecan Naphthyridines Dronabinol Affinity Labels Antigens, CD34 Antineoplastic Agents, Phytogenic Iron Chelating Agents Lactams, Macrocyclic Neoplasm Proteins Cyclohexanols Benzoquinones Triamcinolone Acetonide Bleomycin src-Family Kinases P-Glycoprotein Drug Combinations HIV Protease Inhibitors ATP-Binding Cassette Transporters Cytarabine Deoxycytidine Proto-Oncogene Proteins c-bcl-2 Pyridines Receptors, Steroid Cannabinoid Receptor Modulators Receptors, Granulocyte Colony-Stimulating Factor Tumor Markers, Biological Proto-Oncogene Proteins c-akt Fluorodeoxyglucose F18 Neuroprotective Agents Anti-HIV Agents Imidazoles Taxoids Iron DNA-Binding Proteins Paclitaxel Proto-Oncogene Proteins Trans-Activators

Analytical, Diagnostic and Therapeutic Techniques and Equipment50

Cytogenetic Analysis Treatment Outcome Drug Approval Remission Induction Administration, Oral Disease-Free Survival Drug Administration Schedule Survival Analysis Treatment Failure Salvage Therapy Antineoplastic Combined Chemotherapy Protocols Prognosis Reverse Transcriptase Polymerase Chain Reaction In Situ Hybridization, Fluorescence Retreatment Maximum Tolerated Dose Survival Rate Follow-Up Studies Blood Cell Count Inhibitory Concentration 50 Immunohistochemistry Neoadjuvant Therapy Chromatography, High Pressure Liquid Combined Modality Therapy Area Under Curve Blotting, Western Transplantation, Homologous Infusions, Intravenous Positron-Emission Tomography Drug Screening Assays, Antitumor Hematopoietic Stem Cell Transplantation Clinical Trials as Topic Double-Blind Method DNA Mutational Analysis Drug Stability Karyotyping Drug Therapy, Combination Disease Models, Animal Xenograft Model Antitumor Assays Polymerase Chain Reaction Mass Spectrometry Prospective Studies Gene Expression Profiling Chemotherapy, Adjuvant Drug Evaluation, Preclinical Retrospective Studies Tomography, X-Ray Computed Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Flow Cytometry

Phenomena and Processes32

Genes, abl Drug Resistance, Neoplasm Philadelphia Chromosome Dose-Response Relationship, Drug Apoptosis Time Factors Phosphorylation Drug Synergism Cell Proliferation Chromosomes, Human, Pair 9 Mutation Maximum Tolerated Dose Gene Expression Regulation, Leukemic Cell Survival Signal Transduction Blood Cell Count Inhibitory Concentration 50 Area Under Curve G0 Phase Cell Division Drug Interactions Chromosome Aberrations Gene Expression Regulation, Neoplastic Down-Regulation Cell Death Molecular Structure Gene Expression Tissue Distribution Point Mutation Necrosis Cell Cycle Enzyme Activation

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science1

Health Care13

Treatment Outcome Disease-Free Survival United States Food and Drug Administration Survival Analysis Treatment Failure Survival Rate Follow-Up Studies Area Under Curve Clinical Trials as Topic Double-Blind Method Prospective Studies Retrospective Studies Kaplan-Meier Estimate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Pregnatrienes Fusion Proteins, bcr-abl Antineoplastic Agents Proto-Oncogene Proteins c-kit Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Receptor, Platelet-Derived Growth Factor beta Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Cytogenetic Analysis Genes, abl Drug Resistance, Neoplasm Protein-Tyrosine Kinases Ergoloid Mesylates Deferoxamine Proto-Oncogene Proteins c-abl Gastrointestinal Neoplasms K562 Cells Mesylates Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Pergolide Philadelphia Chromosome Treatment Outcome Fenoldopam Drug Approval Enzyme Inhibitors Remission Induction Pefloxacin Benzoxazines Delavirdine Mastocytosis, Systemic Dose-Response Relationship, Drug Dermatofibrosarcoma Receptors, Platelet-Derived Growth Factor Tubulin Modulators Pralidoxime Compounds Administration, Oral Quinolizines Nelfinavir Naphthalenes Gabexate Fibromatosis, Aggressive Proto-Oncogene Proteins c-sis Cell Line, Tumor Antimitotic Agents Morpholines Disease-Free Survival Pyrroles Cannabinoid Receptor Agonists Ergolines Dihydroergotoxine Cannabinoids Lichenoid Eruptions Drug Administration Schedule Apoptosis Bromocriptine Nausea Harringtonines United States Food and Drug Administration mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Time Factors Phosphorylation Leukemia, Myeloid, Accelerated Phase Drug Synergism Doxazosin Cell Proliferation Rifabutin Indoles Interferon-alpha Primary Myelofibrosis Survival Analysis Neoplasm, Residual Receptors, Glucocorticoid Treatment Failure Vomiting Salvage Therapy Cytogenetics Antineoplastic Combined Chemotherapy Protocols Prognosis Chromosomes, Human, Pair 9 Recurrence Neutropenia Histiocytoma, Malignant Fibrous Dexamethasone Mutation Scleroderma, Systemic STAT5 Transcription Factor Thrombocytopenia Disease Progression Receptors, Cannabinoid

No FAQ available that match "metastatic osimertinib mesylate"